The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Support side: New 13D filer — insiders or holders bought while this setup is live; see the timeline.
Radar 85 (high attention) · dilution pressure high · listing risk high · governance risk low · runway 3.4 mo · strongest signal: New 13D filer (Sep 9, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (negative equity, runway < 6 months) coexists with live selling machinery (convertible note, offering (424b)). Base case is a discounted raise; the question is when, not if.
Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Exchange deficiency plus a structural reason cure is hard (sub-$5M float, negative equity, no cash, or a reverse split already used). Under Nasdaq's 2026 rules (one reverse split per 12 months; $5M MVLS floor with no cure period from Sept 2026) the usual escape hatches are narrower.
Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.
An activist has arrived at a company that needs cash — a potential catalyst, but any financing terms may favour the newcomer. A new active >5% holder appeared while the company is under cash or listing pressure - the classic precursor to a recapitalization, board change, or takeover at a discount.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 80 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 17, 2026 | ▼ Minimum bid deficiency | “min bid” language in 8-K (8-K) filed 2026-09-17 filing | 39 |
| Sep 17, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-17; 19 prior 424B filings in 12m filing | 28 |
| Sep 17, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-17; 19 prior 424B filings in 12m filing | 28 |
| Sep 9, 2026 | ▲ New 13D filer | Schedule 13D filed 2026-09-09 filing | 45 |
| Sep 8, 2026 | ▼ Convertible note | “convertible note” language in 8-K (EX-4.1) filed 2026-09-08 filing | 39 |
| Sep 8, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-4.1) filed 2026-09-08 filing | 34 |
| Sep 8, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-09-08 (accepted 08:40 ET) filing | 32 |
| Sep 8, 2026 | ▼ New debt obligation | 8-K Item 2.03 filed 2026-09-08 (accepted 08:40 ET) filing | 29 |
| Sep 8, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-08; 17 prior 424B filings in 12m filing | 28 |
| Sep 8, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-08; 17 prior 424B filings in 12m filing | 28 |
| Sep 2, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-2.1) filed 2026-09-02 filing | 34 |
| Sep 2, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (EX-2.1) filed 2026-09-02 filing | 32 |
| Sep 2, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-02; 15 prior 424B filings in 12m filing | 28 |
| Sep 2, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-02; 15 prior 424B filings in 12m filing | 28 |
| Sep 1, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-01; 13 prior 424B filings in 12m filing | 28 |
| Sep 1, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-09-01; 13 prior 424B filings in 12m filing | 28 |
| Jun 30, 2026 | ▼ Runway < 6 months | ~3.4 months runway: liquidity $27,265,000 as of 2026-06-30, burn $96,120,722/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 38 |
| Jun 30, 2026 | ▼ Negative equity | Stockholders' equity $-32,671,000 as of 2026-06-30 filing | 31 |
| Jun 30, 2026 | ▼ Cash < current liabilities | Liquidity $27,265,000 vs current liabilities $404,896,000 filing | 22 |
AUID authID Inc. · SOBR SOBR Safe, Inc. · SDST Stardust Power Inc. · ADIL ADIAL PHARMACEUTICALS, INC. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · screener →